ROCKVILLE, Md. — September 11, 2026 — The minimally invasive spine technologies market is projected to reach USD 2.6 billion by 2036, rising from USD 1.6 billion in 2026 at a 5.1% CAGR, according to Fact.MR analysis. The market was valued at USD 1.5 billion in 2025.

Demand is being shaped by the growing adoption of minimally invasive spine surgeries, which use smaller incisions and aim to reduce tissue disruption and recovery time. Rising spine-related disorders, aging populations, and advances in surgical technologies are also supporting demand through 2036.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=14465

Market growth reflects changing spine surgery requirements

The market is expected to add USD 1 billion in absolute dollar value between 2026 and 2036. Hospitals, orthopedic clinics, and ambulatory surgical centers are among the end-use settings covered by the Fact.MR assessment.

Minimally invasive spine technologies include endoscopic systems, percutaneous instruments, navigation platforms, and implants. The report covers procedures and technologies associated with decompression, fusion, and disc replacement.

The shift toward less invasive procedures is tied to specific clinical benefits identified in the supplied Fact.MR analysis. These include smaller incisions, reduced tissue disruption, faster recovery, fewer complications, and shorter hospital stays compared with traditional open spine surgery.

Eric Wichems, President and Chief Executive Officer of Vertos Medical, said, “Allowing patients to get back to what matters most to them is what matters most to us.”

The competitive environment is moderately concentrated. Medtronic plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings, Inc., and NuVasive, Inc. are identified among the key companies profiled in the market.

Fact block: Medtronic plc is a medical technology company that develops and supplies technologies used in spine care, including systems supporting minimally invasive procedures.

Percutaneous fixation holds a major position

Percutaneous pedicle screw-rod fixation is expected to account for 45% of market share in 2026, making it the leading technique identified in the supplied Fact.MR analysis. The approach places screws and rods through small incisions to stabilize the spine while limiting muscle and tissue disruption.

This segment benefits from the broader preference for minimally invasive procedures. The technique is used for spinal stabilization in conditions involving deformities or injuries, according to the report.

Degenerative disc disease is projected to account for 30.3% of market share in 2026. The treatment segment reflects demand associated with a common source of back pain and the use of minimally invasive approaches that can reduce recovery time.

The report's methodology combines primary and desk research. Fact.MR states that interviews were conducted with spine surgeons, technology developers, and hospital procurement specialists. Clinical publications, healthcare industry reports, and regulatory filings were also used.

China and India lead regional growth

China is projected to record the highest CAGR among the countries highlighted, at 6.9% from 2026 to 2036. Growth is associated with healthcare infrastructure development, an aging population, and increasing adoption of minimally invasive spine procedures.

India follows at 6.4% CAGR. The report links this outlook to healthcare investment, increasing awareness of spinal health, and growing access to advanced surgical technologies.

Germany is projected to grow at 5.9% CAGR, while France is expected to record a 5.4% CAGR. The United Kingdom follows with a 4.8% CAGR.

The regional outlook shows a combination of established healthcare infrastructure in Western Europe and expanding surgical access across Asian markets.

Technology development keeps competition active

Technology remains a central competitive factor. In February 2026, Medtronic received FDA clearance for its Stealth AXiS™ surgical system, described in the supplied report as a platform integrating planning, navigation, and robotics into one system. The platform also introduces LiveAlign™ segmental tracking.

[LINK: Medtronic Stealth AXiS™ FDA clearance]

Another development identified in the report concerns Johnson & Johnson and its DePuy Synthes orthopedics business. The supplied industry update dated February 19, 2026, stated that Johnson & Johnson was exploring a sale of the unit for more than $20 billion.

Unilateral biportal endoscopy is another technology trend highlighted for 2026. The technique uses separate access points for an endoscope and surgical instruments, supporting visualization and instrument movement during minimally invasive procedures.

Shambhu Nath Jha, Principal Consultant at Fact.MR, said, “The increasing shift towards minimally invasive spine surgeries, combined with the rising global demand for more efficient and patient-friendly solutions, is accelerating the growth of this market.”

High technology costs and the need for skilled surgeons remain constraints identified in the analysis. These factors may influence adoption rates across individual regions.

Top Reports:

https://adamaamresearch.blogspot.com/2026/09/froth-flotation-equipment-market-gains.html

https://social.mytamam.com/blogs/38889/Froth-Flotation-Equipment-Market-Advances-as-Suppliers-Upgrade-Systems

https://zeuspage.org/blogs/52698/Froth-Flotation-Equipment-Market-Gains-from-Higher-Specification-Systems

https://kaamkaaziclub.com/read-blog/48679

About Fact.MR

Fact.MR is a market research and consulting firm providing market intelligence, forecasts, competitive analysis, and strategic research across industries. Its research covers market sizing, segmentation, regional analysis, company profiling, and long-term forecasts.